{"result": "(\"entity\"<|>PACIENTES TRIBUTARIOS<|>PERSON<|>Patients who are candidates for home artificial nutrition based on specific clinical criteria)\n##\n(\"entity\"<|>NUTRICIÓN ENTERAL DOMICILIARIA<|>EVENT<|>A type of home artificial nutrition that involves delivering nutrients directly to the stomach)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL DOMICILIARIA<|>EVENT<|>A type of home artificial nutrition that involves delivering nutrients directly into the bloodstream)\n##\n(\"entity\"<|>CAQUEXIA TUMORAL<|>EVENT<|>A condition often seen in cancer patients characterized by severe weight loss and muscle wasting)\n##\n(\"entity\"<|>ATENCIÓN PRIMARIA<|>ORGANIZATION<|>Primary care services that provide initial healthcare and support for patients)\n##\n(\"entity\"<|>ATENCIÓN ESPECIALIZADA<|>ORGANIZATION<|>Specialized healthcare services that provide advanced treatment and care for patients)\n##\n(\"relationship\"<|>PACIENTES TRIBUTARIOS<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>Patients who are candidates for home artificial nutrition are those who cannot meet their nutritional needs through natural foods<|>9)\n##\n(\"relationship\"<|>NUTRICIÓN ENTERAL DOMICILIARIA<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>Enteral nutrition is a form of home artificial nutrition that delivers nutrients directly to the stomach<|>8)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL DOMICILIARIA<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>Parenteral nutrition is a form of home artificial nutrition that delivers nutrients directly into the bloodstream<|>8)\n##\n(\"relationship\"<|>CAQUEXIA TUMORAL<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>Cachexia is a condition that may necessitate the use of home artificial nutrition in cancer patients<|>7)\n##\n(\"relationship\"<|>ATENCIÓN PRIMARIA<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>Primary care services are involved in the management and support of patients receiving home artificial nutrition<|>6)\n##\n(\"relationship\"<|>ATENCIÓN ESPECIALIZADA<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>Specialized healthcare services provide advanced care for patients receiving home artificial nutrition<|>6)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: indicación de NAD debe basarse en un programa estructurado que incluya:\n\n1. Adecuada identificación y selección de los pacientes tributarios de este tratamiento (tabla 4).\n\nLos candidatos serán aquellos pacientes en situación clínica estable, que no puedan cubrir sus requerimientos nutricionales con alimentos naturales. Asimismo, es imprescindible la aceptación por parte de la familia de este tipo de soporte, disponer de un domicilio en condiciones aceptables y realizar un entrenamiento correcto en estas técnicas a los familiares y/o al propio enfermo.\n\n| Tabla 4. Criterios generales para la inclusión de pacientes oncológicos en un programa de NAD. |  |  |\n| |--------------------------------------------|------------|---------------|\n| | Indicación |\n| | NED | NPD |\n| Posibilidad de traslado a domicilio | Aconsejable | Imprescindible |\n| Entorno social y familiar favorable | Aconsejable | Imprescindible |\n| Tolerancia demostrada al tratamiento nutricional | Aconsejable | Imprescindible |\n| Comprensión del programa educacional | Aconsejable | Imprescindible |\n| Capacidad del paciente y familia para el manejo de la nutrición de forma segura | Imprescindible | Imprescindible |\n| Expectativas de mejoría de la calidad de vida | Imprescindible | Imprescindible |\n\nNAD: nutrición artificial domiciliaria; NED: nutrición enteral domiciliaria; NPD: nutrición parenteral domiciliaria.\n\nAdaptado de: Gómez Candela C, Iglesias Rosado C, de Cos Blanco AI, Castillo Rabaneda R y Mateo Lobo R\nNutrición artificial domiciliaria en el paciente oncológico. Consultado en http://www.seom.org/es/informacion-sobre-el-cancer/\npublicaciones/429-soporte-nutricional-en-el-paciente-oncologico a 27 de octubre de 2016.\n---\n# BLOQUE: NUTRICIÓN Y ASPECTOS LEGALES\n\n2. Plan de atención individualizado, que establezca:\n* Los objetivos nutricionales a corto y largo plazo específicos para el paciente.\n* La prescripción de la NAD y las normas a seguir en la administración de la nutrición.\n* Las pautas de prevención o tratamiento de las complicaciones que se deriven del tratamiento nutricional.\n* La organización del suministro periódico de la nutrición y los materiales fungibles.\n* El programa de monitorización clínica y analítica previsto, así como la revisión periódica del tratamiento nutricional.\n\n3. Comunicación entre los diferentes especialistas responsables del seguimiento del paciente con NAD.\n   El establecimiento de canales de comunicación directa entre Atención Primaria y Especializada, con el fin de mejorar la calidad de la asistencia, es un factor fundamental en el seguimiento de la NAD. La colaboración entre ambos estamentos será básica para el seguimiento clínico de estos enfermos. La informatización de la historia clínica, cuando esté disponible, puede ser de gran utilidad en este sentido, ya que permitiría registrar y acceder a los últimos datos sobre el estado del paciente, la pauta de nutrición o las incidencias con la terapia nutricional durante el seguimiento.\n\n## 5. Aspectos éticos sobre la nutrición e hidratación artificial\n\nLa nutrición e hidratación artificial deben ser consideradas como intervenciones médicas más allá del simple hecho de proporcionar alivio al paciente. El principal motivo de indicación de nutrición artificial (NA) suele ser proporcionar soporte alimenticio en aquellos pacientes cuya calidad o esperanza de vida pueda mejorar con esta intervención. Sin embargo, la NA no es un tratamiento curativo, por lo que no va a revertir la evolución de la enfermedad terminal. De hecho, puede ser perjudicial en ciertas ocasiones, aumentando la angustia e incomodidad del paciente, al favorecer los síntomas como la disnea, el aumento de las secreciones o la diuresis, necesidad de sondas o de medidas de restricción mecánicas.\n\nPor otro lado, la hidratación intravenosa se ha usado para evitar síntomas que puedan alterar la calidad de vida de los pacientes en fase terminal (como mayor astenia, disminución del nivel de conciencia, alucinaciones), resultado de la hipovolemia y la deshidratación. Por lo tanto, las decisiones sobre el uso de nutrición y/o hidratación artificial pueden ser independientes.\n\n### 5.1. Inicio de nutrición e hidratación artificial\n\nExiste una falta de consenso sobre si la NA resulta o no beneficiosa en el final de la vida. Puede resultar útil en enfermedades degenerativas, como la esclerosis lateral amiotrófica, en complicaciones del cáncer o sus tratamientos. No obstante, diversos estudios hablan de que la nutrición artificial no mejora ni tiene efecto en enfermedades muy avanzadas.\n\nEn pacientes oncológicos con caquexia tumoral existe poca evidencia sobre la influencia de\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>EVENT<|>Nutritional support provided at home for patients who cannot meet their nutritional needs through natural foods)\n##\n(\"entity\"<|>GÓMEZ CANDELA C<|>PERSON<|>Gómez Candela C is an author who contributed to the guidelines on home artificial nutrition for oncological patients)\n##\n(\"entity\"<|>IGLESIAS ROSADO C<|>PERSON<|>Iglesias Rosado C is an author who contributed to the guidelines on home artificial nutrition for oncological patients)\n##\n(\"entity\"<|>DE COS BLANCO AI<|>PERSON<|>De Cos Blanco AI is an author who contributed to the guidelines on home artificial nutrition for oncological patients)\n##\n(\"entity\"<|>CASTILLO RABANEDA R<|>PERSON<|>Castillo Rabaneda R is an author who contributed to the guidelines on home artificial nutrition for oncological patients)\n##\n(\"entity\"<|>MATEO LOBO R<|>PERSON<|>Mateo Lobo R is an author who contributed to the guidelines on home artificial nutrition for oncological patients)\n##\n(\"entity\"<|>SEOM<|>ORGANIZATION<|>SEOM is an organization that provides information and resources related to cancer care and treatment)\n##\n(\"relationship\"<|>GÓMEZ CANDELA C<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>Gómez Candela C authored guidelines on home artificial nutrition for oncological patients<|>8)\n##\n(\"relationship\"<|>IGLESIAS ROSADO C<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>Iglesias Rosado C authored guidelines on home artificial nutrition for oncological patients<|>8)\n##\n(\"relationship\"<|>DE COS BLANCO AI<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>De Cos Blanco AI authored guidelines on home artificial nutrition for oncological patients<|>8)\n##\n(\"relationship\"<|>CASTILLO RABANEDA R<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>Castillo Rabaneda R authored guidelines on home artificial nutrition for oncological patients<|>8)\n##\n(\"relationship\"<|>MATEO LOBO R<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>Mateo Lobo R authored guidelines on home artificial nutrition for oncological patients<|>8)\n##\n(\"relationship\"<|>SEOM<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>SEOM provides resources and information on home artificial nutrition for oncological patients<|>7)\n<|COMPLETE|>"}]}